Home › NDC Lookup › RxCUI directory › RxCUI 2390292

Doxylamine succinate 3.26 MG/ML Oral Solution — RxCUI 2390292

RxNorm drug concept · Semantic clinical drug
RxCUI 2390292 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2390292
Official nameDoxylamine succinate 3.26 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdoxylamine succinate 9.78 MG per 3 mL Oral Solution; doxylamine succinate 9.78 MG in 3 mL Oral Solution
FDA products mapped1
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Doxylamine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Sleep-aid tablets help you fall asleep more easily. Some NyQuil and other liquid or syrup products relieve hay fever and upper respiratory allergy sympto...
  • Adults and children 12 and over take one tablet about 30 minutes before bed, once daily or as your doctor directs. Take it only at bedtime. These tablets are not for children under...
  • No. The label says to avoid alcohol while using doxylamine. Also don’t drive or run machinery.
  • Yes, if you have emphysema or chronic bronchitis, glaucoma, or trouble urinating from an enlarged prostate. Also check if you take sedatives, other sleep aids, or other antihistami...
📖 Read our full Doxylamine guide →

🕸️ Concept Web — How Doxylamine succinate 3.26 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Doxylamine succinate 3.26 MG/ML Oral Solution RxCUI 2390292

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Doxylamine 3642
    • Doxylamine succinate 23665
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Doxylamine Oral Solution 706842
    • Doxylamine succinate Oral Solution 2646002
    • Doxylamine Oral Liquid Product 1160784
    • Doxylamine Oral Product 1160785
    • Doxylamine succinate Oral Liquid Product 2659323
    • Doxylamine succinate Oral Product 2659657
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Doxylamine succinate 3.26 MG/ML 2390291

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Doxylamine succinate 3.26 MG/ML SCDC · 2390291
  • Doxylamine Oral Solution SCDF · 706842
  • Doxylamine succinate Oral Solution SCDFP · 2646002
  • Doxylamine Oral Liquid Product SCDG · 1160784
  • Doxylamine Oral Product SCDG · 1160785
  • Doxylamine succinate Oral Liquid Product SCDGP · 2659323
  • Doxylamine succinate Oral Product SCDGP · 2659657

📦 FDA Products & Package NDCs

1 product · 4 package NDCs
4 package NDCs map to RxCUI 2390292 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
60665-0003-01 1 BOTTLE in 1 CARTON (60665-003-01) / 100 mL in 1 BOTTLE Sambrosa Night Sambrosa Care, Inc. 2020-01-10
60665-0003-02 1 BOTTLE in 1 CARTON (60665-003-02) / 30 mL in 1 BOTTLE Sambrosa Night Sambrosa Care, Inc. 2020-12-01
60665-0003-03 1 BOTTLE in 1 CARTON (60665-003-03) / 300 mL in 1 BOTTLE Sambrosa Night Sambrosa Care, Inc. 2020-01-10
60665-0003-04 3 mL in 1 POUCH (60665-003-04) Sambrosa Night Sambrosa Care, Inc. 2021-10-26
Observed labelers: Sambrosa Care, Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.